Curating
Fundraising
AMM
900M to ~2B
Global 60+ population to double by 2050
$100B
Longevity therapeutics market by 2030
$1T +
Healthcare costs for aging diseases
By 2050, a doubled global 60+ population (2B) drives a ~$100B longevity market, incentivizing research to reduce disease burden and healthcare costs.
Longevity research is an interdisciplinary field dedicated to understanding and slowing the biological mechanisms of aging, ultimately aiming to extend healthy human lifespans. The problem space spans a massive and urgent need: as populations age, ag...
Longevity
Longevity research focuses on understanding and extending the human lifespan by targeting biological aging processes. This includes studying genetics, metabolism, and cellular pathways to develop therapies that reduce age-related diseases and promote healthier, longer lives.
Healthspan
Healthspan research aims to maximize the period of life spent in good health by preventing or delaying age-related diseases. It emphasizes improving physical and cognitive well-being, ensuring that longer lifespans are accompanied by enhanced quality of life.
Rejuvenation
Rejuvenation research explores reversing biological aging at the cellular and molecular levels. By targeting damage accumulation and reactivating youthful pathways, it seeks to restore tissue function, repair age-related decline, and rejuvenate the body’s systems.
64,298,880
Total Supply
＠vita_dao on 𝕏
Discord community
VitaDAO’s value capture is driven by a continuous, self-reinforcing cycle connecting decentralized research funding with IP creation, tokenization, and monetization. The DAO begins by pooling treasury funds from its community of token holders, then c...
Nature Aging
The economic value of targeting aging
Nature Biotechnology
The community of the DAO
Nature Biotechnology
